Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.
about
Inflammation, oxidative stress and renin angiotensin system in atherosclerosisImplications of autophagy for vascular smooth muscle cell function and plasticityEndogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart diseaseCardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation.Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta.Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.Toll-like receptor 4 mediates inflammatory cytokine secretion in smooth muscle cells induced by oxidized low-density lipoprotein.Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.Beyond vascular inflammation--recent advances in understanding atherosclerosis.Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesionEngineering nanomaterials to address cell-mediated inflammation in atherosclerosis.IRGM1 regulates oxidized LDL uptake by macrophage via actin-dependent receptor internalization during atherosclerosis.Lipid droplet-associated proteins in atherosclerosis (Review).Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase.Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.Molecular biology of atherosclerosis.Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis.ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.Monocytes: a novel drug delivery system targeting atherosclerosis.Eating the Dead to Keep Atherosclerosis at Bay.Murine aortic smooth muscle cells acquire, though fail to present exogenous protein antigens on major histocompatibility complex class II moleculesCombination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice.Increased oxidative stress in foam cells obtained from hemodialysis patients.A Phenanthrene Derivative, 5,7-Dimethoxy-1,4-Phenanthrenequinone, Inhibits Cell Adhesion Molecule Expression and Migration in Vascular Endothelial and Smooth Muscle Cells.Macrophages and lipid metabolism.Smooth Muscle Cell Fate and Plasticity in Atherosclerosis.The critical role of ABCG1 and PPARγ/LXRα signaling in TLR4 mediates inflammatory responses and lipid accumulation in vascular smooth muscle cells.Counteractive effects of omentin-1 against atherogenesis†.Is triglyceride/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease?Differential Effect of Hypoxia in Human and Mouse Vascular Smooth Muscle Cell Migration through LRP1-pPyk2-MMP-9 Axis
P2860
Q26795756-6D1DDE13-AE58-4F99-A376-0CE5DC591BA2Q26863422-CA134D2D-CDD7-4B62-96CE-D16FFC2174C6Q27010136-6FB561CD-3649-4520-AD0E-9996C29E46FBQ29347161-E24DD441-E8D0-42A0-BAEB-7C4C5637B7F3Q34610945-6536489D-0AF5-41B7-8746-BEB91368E1D8Q34744031-415BE6D3-DF6B-4025-BBBF-56CF2D59FD05Q35043344-4D7D67F1-E9C1-43FF-9364-0CD880B18B1AQ35130704-459566E0-3421-4659-8C5B-E59C70FD4715Q35154870-B1885085-D5B5-4D07-821C-B9BEFD9FC057Q35852679-54C54E95-667C-4FA2-9D82-6234BED888F5Q36079808-B0078796-0DE8-4F1F-B5A0-C450BA210274Q36586068-B4A6D543-E5F0-4EB5-BE9D-19030F26236AQ36848196-FB44FD94-5A43-4585-BB30-E55BB1E28215Q36860169-6F1C84D6-ACC3-4527-A8E0-BA90EE6EDAA3Q36931267-58B4E19E-701F-454E-9429-57F67DAF3E81Q37225813-5826880E-BCB7-436A-BED6-FED2AE6DF1D2Q37470658-43EA0D33-D8EE-42EC-8441-B3B19400BEFCQ38125279-9120FA25-2518-484C-A257-EDD6BBFA7A45Q38232998-A5B0C591-9C11-4698-9C7D-46D22D014CD0Q38835289-FCFB28FA-F042-40E0-A6A7-4E764F9CBF85Q39081119-CC4998A3-18F0-4AD3-AD61-42CC71F2C7D2Q39134393-E18FEA1A-7CA1-4648-9CA7-95CF163C2648Q41829263-6A8842BD-C7AD-4B31-8D9F-7576A5E790A4Q42293087-B587A4A5-25D8-46D0-B0B1-0DB9D29E8DD3Q44020224-1147F0CA-3096-41D9-B873-16FD219B711EQ46407757-C7BD9905-D585-42C1-BD04-45A4FA73DA2DQ49026058-FFB7F342-CFE7-4E02-A082-E9A2111C9BDAQ49551883-69069701-CF76-4C53-B7ED-C10055802AC1Q51347960-B66F94B7-670D-47D2-A31A-6A2E55A2C948Q53800814-5E8D2BE3-A9FE-46AA-8027-EE72C703CD03Q55031386-633E909D-6DD8-4B26-94C5-CCC7B115CC9BQ59103206-37F562A3-7075-4321-8628-C8C585031D69
P2860
Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Contribution of monocyte-deriv ...... arterial foam cell formation.
@en
Contribution of monocyte-deriv ...... arterial foam cell formation.
@nl
type
label
Contribution of monocyte-deriv ...... arterial foam cell formation.
@en
Contribution of monocyte-deriv ...... arterial foam cell formation.
@nl
prefLabel
Contribution of monocyte-deriv ...... arterial foam cell formation.
@en
Contribution of monocyte-deriv ...... arterial foam cell formation.
@nl
P2093
P2860
P356
P1476
Contribution of monocyte-deriv ...... arterial foam cell formation.
@en
P2093
Gordon A Francis
Parveer S Pannu
Sima Allahverdian
P2860
P304
P356
10.1093/CVR/CVS094
P577
2012-02-15T00:00:00Z